BACTERIOSTATIC WATER

BACTERIOSTATIC WATER was reported 415 times

BACTERIOSTATIC WATER is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LEPTIN LEVEL DECREASED 2 0.5000
1 VASCULAR RINGS AND SLINGS 1 0.1429
2 LEPTIN LEVEL INCREASED 1 0.0909
3 CAPRIPOX VIRAL INFECTION 1 0.0588
4 LYSOSOMAL STORAGE DISORDER 1 0.0526
5 NASAL MUCOSAL HYPERTROPHY 1 0.0500
6 BILATERAL BREAST BUDS 1 0.0294
7 PRODUCT STERILITY LACKING 2 0.0238
8 ANGIOKERATOMA 2 0.0235
9 MEDICAL DEVICE SITE HAEMATOMA 1 0.0217
10 MALASSEZIA INFECTION 1 0.0147
11 DIET NONCOMPLIANCE 5 0.0136
12 GENDER DYSPHORIA 1 0.0114
13 PRODUCT ADVERTISING ISSUE 2 0.0093
14 EXPOSURE VIA INHALATION 2 0.0093
15 BLOOD TRIGLYCERIDES DECREASED 3 0.0089
16 NEOPLASM OF APPENDIX 1 0.0088
17 PRODUCT STERILITY ISSUE 1 0.0081
18 NEUTRALISING ANTIBODIES 1 0.0079
19 SKELETAL DYSPLASIA 1 0.0070
20 ADNEXAL TORSION 2 0.0063
21 ENDOMETRIAL CANCER METASTATIC 1 0.0062
22 ADNEXA UTERI CYST 1 0.0062
23 DEFORMITY THORAX 1 0.0052
24 FAT TISSUE DECREASED 2 0.0051
25 DEAFNESS PERMANENT 1 0.0051
26 XANTHOMA 1 0.0050
27 NEUTRALISING ANTIBODIES POSITIVE 2 0.0048
28 ZINC DEFICIENCY 1 0.0047
29 INSULIN RESISTANCE 8 0.0038
30 PRODUCT CLOSURE ISSUE 2 0.0036
31 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
32 UMBILICAL HERNIA REPAIR 1 0.0034
33 POST PROCEDURAL PNEUMONIA 1 0.0033
34 MALABSORPTION FROM INJECTION SITE 1 0.0032
35 ANOREXIA NERVOSA 1 0.0031
36 LORDOSIS 1 0.0028
37 TINEA VERSICOLOUR 1 0.0028
38 ADENOIDAL HYPERTROPHY 1 0.0026
39 CONVULSIVE THRESHOLD LOWERED 1 0.0025
40 ANHIDROSIS 1 0.0025
41 LAGOPHTHALMOS 1 0.0024
42 PANCREATITIS RELAPSING 2 0.0024
43 BIOPSY LIVER 1 0.0024
44 HIP DEFORMITY 1 0.0023
45 INFUSION SITE SCAR 1 0.0023
46 TOOTH IMPACTED 1 0.0022
47 GASTRIC VARICES 1 0.0021
48 PENILE CONTUSION 1 0.0021
49 MACROGLOSSIA 1 0.0018
50 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
51 OESOPHAGEAL FOOD IMPACTION 1 0.0018
52 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 1 0.0018
53 MEDICAL DEVICE SITE PAIN 1 0.0018
54 EYE ULCER 1 0.0017
55 MOTOR DEVELOPMENTAL DELAY 1 0.0017
56 VITAMIN D INCREASED 1 0.0016
57 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
58 BODY MASS INDEX INCREASED 2 0.0015
59 CYST RUPTURE 1 0.0015
60 CORNEAL OPACITY 2 0.0015
61 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
62 PRODUCT PREPARATION ISSUE 9 0.0014
63 CHLAMYDIAL INFECTION 1 0.0013
64 CARBOHYDRATE ANTIGEN 15-3 INCREASED 1 0.0013
65 EXTRADURAL ABSCESS 1 0.0013
66 PRODUCT SUPPLY ISSUE 9 0.0013
67 GLYCOSYLATED HAEMOGLOBIN DECREASED 2 0.0012
68 KETONURIA 1 0.0012
69 INTERCEPTED PRODUCT DISPENSING ERROR 2 0.0012
70 TONSILLAR HYPERTROPHY 2 0.0012
71 ENDOCRINE OPHTHALMOPATHY 1 0.0012
72 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
73 ANAEMIA OF CHRONIC DISEASE 1 0.0011
74 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
75 PSYCHOGENIC SEIZURE 1 0.0011
76 INJECTION SITE SCAR 3 0.0011
77 SKIN TEXTURE ABNORMAL 1 0.0010
78 HYPERTRIGLYCERIDAEMIA 6 0.0010
79 RESPIRATORY TRACT IRRITATION 1 0.0010
80 PRODUCT NAME CONFUSION 1 0.0009
81 IMMEDIATE POST-INJECTION REACTION 1 0.0009
82 ESSENTIAL TREMOR 1 0.0009
83 STRESS AT WORK 1 0.0009
84 CARBON DIOXIDE DECREASED 1 0.0009
85 LUMBAR RADICULOPATHY 1 0.0009
86 ALLODYNIA 1 0.0009
87 DEVICE DISPENSING ERROR 1 0.0008
88 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
89 LIBIDO DISORDER 1 0.0008
90 HYPERPHAGIA 3 0.0008
91 DRUG SPECIFIC ANTIBODY 1 0.0007
92 RHONCHI 1 0.0007
93 FAT TISSUE INCREASED 1 0.0007
94 KNEE DEFORMITY 1 0.0007
95 DIABETIC FOOT 2 0.0007
96 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
97 NON-CARDIAC CHEST PAIN 2 0.0006
98 PANCREATIC DISORDER 3 0.0006
99 SEBORRHOEIC DERMATITIS 1 0.0006
100 GASTRIC DILATATION 1 0.0006
101 VEIN RUPTURE 1 0.0006
102 SPLEEN DISORDER 1 0.0006
103 EXPOSURE TO SARS-COV-2 1 0.0006
104 CERVICAL SPINAL STENOSIS 1 0.0006
105 THYROIDECTOMY 1 0.0006
106 OTORRHOEA 1 0.0006
107 SKIN HYPOPIGMENTATION 1 0.0006
108 PRODUCT TAMPERING 1 0.0006
109 BODY TEMPERATURE ABNORMAL 1 0.0005
110 HYPERTRICHOSIS 1 0.0005
111 BLOOD CHOLESTEROL DECREASED 1 0.0005
112 BLOOD BICARBONATE DECREASED 1 0.0005
113 GUN SHOT WOUND 1 0.0005
114 GINGIVAL RECESSION 1 0.0005
115 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
116 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
117 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
118 ATRIAL THROMBOSIS 1 0.0005
119 POOR VENOUS ACCESS 5 0.0005
120 MICROCYTIC ANAEMIA 1 0.0005
121 LIVEDO RETICULARIS 1 0.0005
122 INFUSION SITE BRUISING 1 0.0005
123 THERAPY INTERRUPTED 33 0.0005
124 ENDOMETRIAL CANCER 1 0.0005
125 INFUSION SITE INFECTION 1 0.0004
126 PANCREATITIS CHRONIC 1 0.0004
127 WEIGHT ABNORMAL 1 0.0004
128 PRODUCT PACKAGING CONFUSION 1 0.0004
129 HORMONE LEVEL ABNORMAL 2 0.0004
130 HAEMATOLOGICAL INFECTION 1 0.0004
131 GLOMERULONEPHRITIS 1 0.0004
132 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
133 GASTROINTESTINAL TUBE INSERTION 1 0.0004
134 VENTRICULAR HYPERTROPHY 1 0.0004
135 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
136 ABNORMAL UTERINE BLEEDING 1 0.0004
137 MEAN CELL VOLUME INCREASED 1 0.0004
138 HEPATOSPLENOMEGALY 1 0.0004
139 LIPOMA 1 0.0004
140 RADICULOPATHY 1 0.0004
141 ANIMAL BITE 1 0.0004
142 MIGRAINE WITH AURA 1 0.0004
143 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
144 INTENTIONAL DOSE OMISSION 10 0.0004
145 PRODUCT CONTAINER ISSUE 3 0.0003
146 METABOLIC DISORDER 2 0.0003
147 METABOLIC ENCEPHALOPATHY 1 0.0003
148 TYPE 1 DIABETES MELLITUS 2 0.0003
149 CENTRAL VENOUS CATHETERISATION 1 0.0003
150 INJECTION SITE VESICLES 2 0.0003
151 INFUSION SITE EXTRAVASATION 2 0.0003
152 PRODUCT USE COMPLAINT 5 0.0003
153 NEEDLE ISSUE 9 0.0003
154 VITAMIN D DEFICIENCY 3 0.0003
155 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
156 DEAFNESS NEUROSENSORY 1 0.0003
157 SKIN INJURY 1 0.0003
158 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
159 DIABETIC RETINOPATHY 1 0.0003
160 TEMPERATURE INTOLERANCE 3 0.0003
161 LEFT VENTRICULAR FAILURE 1 0.0003
162 PRODUCT CONTAMINATION 1 0.0003
163 PHARYNGITIS STREPTOCOCCAL 3 0.0003
164 SKIN LACERATION 3 0.0003
165 HEPATIC STEATOSIS 5 0.0003
166 PRODUCT DOSE OMISSION ISSUE 78 0.0003
167 SNORING 1 0.0003
168 PRODUCT STORAGE ISSUE 1 0.0003
169 INCREASED APPETITE 5 0.0003
170 INSURANCE ISSUE 4 0.0003
171 OESOPHAGEAL DISORDER 1 0.0003
172 PROSTATOMEGALY 1 0.0003
173 NAIL DISCOLOURATION 1 0.0003
174 THERAPY CESSATION 13 0.0003
175 EXPOSURE VIA BREAST MILK 1 0.0003
176 VITAMIN B12 DEFICIENCY 1 0.0002
177 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
178 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
179 PRODUCT DISPENSING ISSUE 1 0.0002
180 SYRINGE ISSUE 4 0.0002
181 BLOOD CALCIUM INCREASED 2 0.0002
182 ONYCHOMYCOSIS 1 0.0002
183 RHINITIS ALLERGIC 1 0.0002
184 IRON DEFICIENCY 1 0.0002
185 SUSPECTED OFF LABEL USE 1 0.0002
186 INJECTION SITE PAPULE 1 0.0002
187 EYE OPERATION 1 0.0002
188 NERVE COMPRESSION 2 0.0002
189 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
190 PRE-ECLAMPSIA 1 0.0002
191 RECALLED PRODUCT ADMINISTERED 2 0.0002
192 SUBCUTANEOUS ABSCESS 1 0.0002
193 BLOOD GLUCOSE DECREASED 10 0.0002
194 AUTOIMMUNE DISORDER 2 0.0002
195 HEPATOMEGALY 2 0.0002
196 BODY TEMPERATURE DECREASED 2 0.0002
197 NASAL POLYPS 1 0.0002
198 FOOT OPERATION 1 0.0002
199 TREATMENT NONCOMPLIANCE 11 0.0002
200 INJECTION SITE INFLAMMATION 1 0.0002
201 OVARIAN CYST 2 0.0002
202 HYPERAMMONAEMIA 1 0.0002
203 VEIN DISORDER 1 0.0002
204 DYSLIPIDAEMIA 1 0.0002
205 AMMONIA INCREASED 1 0.0002
206 WEIGHT LOSS POOR 1 0.0002
207 INITIAL INSOMNIA 2 0.0002
208 PRODUCT PREPARATION ERROR 4 0.0002
209 PERIPHERAL VASCULAR DISORDER 1 0.0002
210 PERIORBITAL OEDEMA 1 0.0002
211 HYPERGLYCAEMIA 7 0.0002
212 WEIGHT INCREASED 43 0.0002
213 SENSITIVITY TO WEATHER CHANGE 1 0.0002
214 HYPOGLYCAEMIA 9 0.0002
215 BEHAVIOUR DISORDER 1 0.0002
216 HIP SURGERY 1 0.0002
217 BLOOD GLUCOSE FLUCTUATION 2 0.0002
218 DEAFNESS UNILATERAL 1 0.0002
219 HYPERKERATOSIS 1 0.0002
220 FOOT DEFORMITY 2 0.0002
221 NERVE INJURY 2 0.0002
222 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
223 CHOLECYSTECTOMY 2 0.0002
224 HYPERSOMNIA 5 0.0002
225 EXERCISE TOLERANCE DECREASED 1 0.0002
226 PRODUCT LABEL CONFUSION 1 0.0002
227 HYPOVOLAEMIA 1 0.0002
228 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
229 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
230 CARDIAC PACEMAKER INSERTION 1 0.0002
231 DIABETIC KETOACIDOSIS 4 0.0002
232 OSTEOMYELITIS 3 0.0002
233 PLATELET COUNT ABNORMAL 1 0.0002
234 BLOOD GLUCOSE ABNORMAL 3 0.0002
235 INJECTION SITE DISCOLOURATION 2 0.0002
236 SWELLING OF EYELID 1 0.0002
237 INJECTION SITE IRRITATION 2 0.0002
238 TOOTH INFECTION 2 0.0002
239 APPETITE DISORDER 1 0.0002
240 PRODUCT ADMINISTRATION ERROR 3 0.0001
241 ILLNESS 15 0.0001
242 HUNGER 2 0.0001
243 HAND FRACTURE 1 0.0001
244 WEIGHT DECREASED 39 0.0001
245 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
246 INTENTIONAL UNDERDOSE 1 0.0001
247 SENSITIVE SKIN 1 0.0001
248 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
249 INJECTION SITE MASS 5 0.0001
250 AORTIC ANEURYSM 1 0.0001
251 DIABETES MELLITUS 10 0.0001
252 ACIDOSIS 1 0.0001
253 ATRIOVENTRICULAR BLOCK 1 0.0001
254 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
255 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
256 CYSTITIS 4 0.0001
257 PREMATURE DELIVERY 2 0.0001
258 ATRIAL FLUTTER 1 0.0001
259 SENSORY LOSS 1 0.0001
260 MYASTHENIA GRAVIS 1 0.0001
261 FRUSTRATION TOLERANCE DECREASED 1 0.0001
262 MUSCLE DISORDER 1 0.0001
263 IMPAIRED HEALING 4 0.0001
264 HYPERAESTHESIA 1 0.0001
265 HAIR DISORDER 1 0.0001
266 LIVE BIRTH 1 0.0001
267 BLOOD MAGNESIUM DECREASED 1 0.0001
268 ILL-DEFINED DISORDER 7 0.0001
269 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
270 RESPIRATORY RATE INCREASED 1 0.0001
271 HEAVY MENSTRUAL BLEEDING 1 0.0001
272 HOSPITALISATION 17 0.0001
273 INCREASED TENDENCY TO BRUISE 1 0.0001
274 OVARIAN CANCER 1 0.0001
275 IRON DEFICIENCY ANAEMIA 1 0.0001
276 PRODUCT DISTRIBUTION ISSUE 1 0.0001
277 THINKING ABNORMAL 2 0.0001
278 HEPATIC ENCEPHALOPATHY 1 0.0001
279 APPENDICITIS 1 0.0001
280 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
281 FOOT FRACTURE 2 0.0001
282 PROTEINURIA 2 0.0001
283 SLEEP APNOEA SYNDROME 2 0.0001
284 POST PROCEDURAL COMPLICATION 2 0.0001
285 LOWER LIMB FRACTURE 2 0.0001
286 PRESCRIBED OVERDOSE 2 0.0001
287 THERAPY CHANGE 1 0.0001
288 LABORATORY TEST ABNORMAL 3 0.0001
289 SINUS DISORDER 2 0.0001
290 RESPIRATORY DISORDER 3 0.0001
291 HYPOTONIA 1 0.0001
292 TASTE DISORDER 2 0.0001
293 TOOTH ABSCESS 1 0.0001
294 SUBARACHNOID HAEMORRHAGE 1 0.0001
295 EAR DISCOMFORT 1 0.0001
296 HELICOBACTER INFECTION 1 0.0001
297 INJECTION SITE DISCOMFORT 1 0.0001
298 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
299 RENAL PAIN 1 0.0001
300 BREAST PAIN 1 0.0001
301 BACK INJURY 1 0.0001
302 PRODUCT PRESCRIBING ISSUE 2 0.0001
303 DENTAL CARIES 1 0.0001
304 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
305 SNEEZING 2 0.0001
306 THROAT IRRITATION 4 0.0001
307 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
308 HEART RATE IRREGULAR 2 0.0001
309 TINNITUS 4 0.0001
310 PERICARDIAL EFFUSION 2 0.0001
311 DECREASED APPETITE 20 0.0001
312 BURNING SENSATION 6 0.0001
313 COVID-19 15 0.0001
314 SPLENOMEGALY 1 0.0001
315 BLOOD GLUCOSE INCREASED 16 0.0001
316 BLOOD IRON DECREASED 1 0.0001
317 PRODUCT PRESCRIBING ERROR 2 0.0001
318 ACCIDENT 1 0.0001
319 BURSITIS 1 0.0001
320 ADRENAL INSUFFICIENCY 1 0.0001
321 NOCTURIA 1 0.0001
322 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
323 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
324 SMALL INTESTINAL OBSTRUCTION 1 0.0001
325 INJECTION SITE EXTRAVASATION 1 0.0001
326 ABNORMAL WEIGHT GAIN 1 0.0001
327 ILEUS 1 0.0001
328 TOOTH EXTRACTION 1 0.0001
329 AGEUSIA 2 0.0001
330 MUSCLE ATROPHY 1 0.0001
331 HYPOPHAGIA 2 0.0001
332 ROTATOR CUFF SYNDROME 1 0.0001
333 SKIN ULCER 2 0.0001
334 HAEMATOMA 2 0.0001
335 INJECTION SITE INDURATION 1 0.0001
336 SARS-COV-2 TEST POSITIVE 1 0.0001
337 INFUSION RELATED REACTION 5 0.0001
338 SINUS CONGESTION 1 0.0001
339 TACHYPNOEA 1 0.0001
340 IMPAIRED GASTRIC EMPTYING 1 0.0001
341 MENTAL STATUS CHANGES 2 0.0001
342 BLOOD TEST ABNORMAL 1 0.0001
343 SEASONAL ALLERGY 1 0.0001
344 RED BLOOD CELL COUNT DECREASED 2 0.0001
345 PARAESTHESIA 11 0.0001
346 ANGINA PECTORIS 2 0.0001
347 CARDIOGENIC SHOCK 1 0.0001
348 IMPAIRED QUALITY OF LIFE 1 0.0001
349 INFECTION 10 0.0001
350 ANOSMIA 1 0.0001
351 INTENTIONAL PRODUCT MISUSE 6 0.0001
352 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
353 CARDIOMYOPATHY 1 0.0001
354 BRONCHITIS 5 0.0001
355 SKIN HAEMORRHAGE 1 0.0001
356 BONE LOSS 1 0.0001
357 BLOOD POTASSIUM DECREASED 2 0.0001
358 SKIN DISCOLOURATION 3 0.0001
359 INJECTION SITE SWELLING 5 0.0001
360 INJECTION SITE RASH 2 0.0001
361 DEVICE RELATED INFECTION 1 0.0001
362 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
363 THYROID DISORDER 1 0.0001
364 LIMB DISCOMFORT 2 0.0001
365 MUSCULOSKELETAL CHEST PAIN 1 0.0001
366 ANKLE FRACTURE 1 0.0001
367 DELUSION 1 0.0001
368 INFLUENZA 7 0.0001
369 SCIATICA 1 0.0001
370 HYPOTHYROIDISM 2 0.0001
371 INJECTION SITE HAEMORRHAGE 5 0.0001
372 MUSCLE TIGHTNESS 1 0.0001
373 EXPIRED PRODUCT ADMINISTERED 2 0.0001
374 CYTOMEGALOVIRUS INFECTION 1 0.0001
375 SKIN DISORDER 2 0.0001
376 AGGRESSION 3 0.0001
377 BLOOD UREA INCREASED 1 0.0001
378 INJECTION SITE PRURITUS 4 0.0001
379 CELLULITIS 3 0.0001
380 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
381 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
382 SINUSITIS 6 0.0001
383 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
384 PRODUCT STORAGE ERROR 5 0.0001
385 HYPERKALAEMIA 2 0.0001
386 PANCREATITIS 3 0.0001
387 LYMPHOCYTE COUNT DECREASED 1 0.0001
388 LYMPHADENOPATHY 2 0.0001
389 HEAD DISCOMFORT 1 0.0001
390 INJECTION SITE ERYTHEMA 7 0.0001
391 GALLBLADDER DISORDER 1 0.0001
392 THIRST 1 0.0001
393 GASTROENTERITIS VIRAL 1 0.0001
394 END STAGE RENAL DISEASE 1 0.0001
395 SWELLING 5 0.0001
396 BLOOD SODIUM DECREASED 1 0.0001
397 UNEVALUABLE EVENT 4 0.0001
398 HEADACHE 33 0.0001
399 INJECTION SITE PAIN 16 0.0001
400 ACUTE RESPIRATORY FAILURE 1 0.0001
401 GLAUCOMA 1 0.0001
402 EAR PAIN 1 0.0001
403 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
404 NASAL CONGESTION 3 0.0001
405 BLOOD PRESSURE ABNORMAL 1 0.0001
406 SPINAL FRACTURE 1 0.0000
407 BODY TEMPERATURE INCREASED 1 0.0000
408 INJECTION SITE WARMTH 1 0.0000
409 JOINT INJURY 1 0.0000
410 IRRITABLE BOWEL SYNDROME 1 0.0000
411 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
412 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
413 PAIN 28 0.0000
414 LIVER DISORDER 2 0.0000
415 PANCREATITIS ACUTE 1 0.0000
416 NO ADVERSE EVENT 8 0.0000
417 PRODUCT AVAILABILITY ISSUE 1 0.0000
418 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
419 NASOPHARYNGITIS 8 0.0000
420 RASH ERYTHEMATOUS 2 0.0000
421 BLOOD PRESSURE FLUCTUATION 1 0.0000
422 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
423 LOCALISED INFECTION 1 0.0000
424 INJECTION SITE URTICARIA 1 0.0000
425 PYREXIA 14 0.0000
426 SYNCOPE 4 0.0000
427 HAEMATEMESIS 1 0.0000
428 FLUSHING 4 0.0000
429 COUGH 11 0.0000
430 UNRESPONSIVE TO STIMULI 1 0.0000
431 DIPLOPIA 1 0.0000
432 DEPRESSED MOOD 2 0.0000
433 EAR INFECTION 1 0.0000
434 CARDIAC FAILURE CONGESTIVE 3 0.0000
435 BLOOD BILIRUBIN INCREASED 1 0.0000
436 FREQUENT BOWEL MOVEMENTS 1 0.0000
437 THROAT TIGHTNESS 1 0.0000
438 INFLUENZA LIKE ILLNESS 3 0.0000
439 RESPIRATORY ARREST 1 0.0000
440 RESPIRATORY DISTRESS 1 0.0000
441 ANAPHYLACTIC REACTION 2 0.0000
442 CONDITION AGGRAVATED 11 0.0000
443 TREMOR 6 0.0000
444 FEELING COLD 1 0.0000
445 DEMENTIA 1 0.0000
446 MUSCULAR WEAKNESS 4 0.0000
447 SOMNOLENCE 7 0.0000
448 SEIZURE 4 0.0000
449 PANCREATIC CARCINOMA 1 0.0000
450 CHILLS 4 0.0000
451 SURGERY 2 0.0000
452 ASCITES 1 0.0000
453 WHEEZING 2 0.0000
454 ADVERSE DRUG REACTION 3 0.0000
455 PREMATURE BABY 1 0.0000
456 HEPATIC FAILURE 1 0.0000
457 CORONARY ARTERY DISEASE 1 0.0000
458 DISCOMFORT 2 0.0000
459 ADVERSE EVENT 3 0.0000
460 PERIPHERAL SWELLING 5 0.0000
461 EMOTIONAL DISORDER 1 0.0000
462 FEMUR FRACTURE 1 0.0000
463 NERVOUS SYSTEM DISORDER 1 0.0000
464 SWOLLEN TONGUE 1 0.0000
465 OFF LABEL USE 28 0.0000
466 HEAD INJURY 1 0.0000
467 NEUROPATHY PERIPHERAL 3 0.0000
468 MIGRAINE 3 0.0000
469 METABOLIC ACIDOSIS 1 0.0000
470 PRURITUS 12 0.0000
471 HIP FRACTURE 1 0.0000
472 HYPERHIDROSIS 4 0.0000
473 NIGHT SWEATS 1 0.0000
474 LACTIC ACIDOSIS 1 0.0000
475 SWELLING FACE 2 0.0000
476 PRODUCT DOSE OMISSION 2 0.0000
477 DYSPEPSIA 3 0.0000
478 OSTEONECROSIS 1 0.0000
479 BACK PAIN 7 0.0000
480 VIRAL INFECTION 1 0.0000
481 FUNGAL INFECTION 1 0.0000
482 DEHYDRATION 4 0.0000
483 URTICARIA 5 0.0000
484 TYPE 2 DIABETES MELLITUS 1 0.0000
485 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
486 HAEMATURIA 1 0.0000
487 ABDOMINAL PAIN UPPER 6 0.0000
488 INJECTION SITE REACTION 2 0.0000
489 DELIRIUM 1 0.0000
490 ABDOMINAL DISTENSION 3 0.0000
491 HEART RATE DECREASED 1 0.0000
492 DEVICE MALFUNCTION 2 0.0000
493 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
494 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
495 ANXIETY 8 0.0000
496 MOBILITY DECREASED 2 0.0000
497 VOMITING 13 0.0000
498 CRYING 1 0.0000
499 MALAISE 12 0.0000
500 HYPERSENSITIVITY 5 0.0000
501 EYE SWELLING 1 0.0000
502 DYSARTHRIA 1 0.0000
503 DYSPNOEA EXERTIONAL 1 0.0000
504 INTESTINAL OBSTRUCTION 1 0.0000
505 INCORRECT DOSE ADMINISTERED 6 0.0000
506 ANAEMIA 5 0.0000
507 ABNORMAL BEHAVIOUR 1 0.0000
508 INJECTION SITE BRUISING 2 0.0000
509 ABORTION SPONTANEOUS 1 0.0000
510 THROMBOSIS 2 0.0000
511 JOINT SWELLING 3 0.0000
512 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
513 EXTRA DOSE ADMINISTERED 1 0.0000
514 DYSKINESIA 1 0.0000
515 ASTHENIA 9 0.0000
516 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
517 CARDIO-RESPIRATORY ARREST 1 0.0000
518 ROAD TRAFFIC ACCIDENT 1 0.0000
519 CEREBROVASCULAR ACCIDENT 4 0.0000
520 URINARY TRACT INFECTION 4 0.0000
521 HYPOACUSIS 1 0.0000
522 BALANCE DISORDER 2 0.0000
523 DEVICE DISLOCATION 1 0.0000
524 MENTAL DISORDER 1 0.0000
525 INSOMNIA 6 0.0000
526 COLITIS ULCERATIVE 1 0.0000
527 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
528 DEPRESSION 5 0.0000
529 MEMORY IMPAIRMENT 3 0.0000
530 FATIGUE 17 0.0000
531 NEPHROLITHIASIS 1 0.0000
532 HYPOKALAEMIA 1 0.0000
533 CHEST PAIN 4 0.0000
534 ABDOMINAL PAIN 5 0.0000
535 BLOOD CHOLESTEROL INCREASED 1 0.0000
536 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
537 DYSPHAGIA 2 0.0000
538 MULTIPLE SCLEROSIS 1 0.0000
539 FEELING ABNORMAL 5 0.0000
540 DRUG INTOLERANCE 2 0.0000
541 RASH 9 0.0000
542 ALOPECIA 4 0.0000
543 PAIN IN EXTREMITY 6 0.0000
544 HEART RATE INCREASED 2 0.0000
545 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
546 HYPOAESTHESIA 3 0.0000
547 HYPOTENSION 4 0.0000
548 FLUID RETENTION 1 0.0000
549 ACUTE KIDNEY INJURY 3 0.0000
550 CHEST DISCOMFORT 2 0.0000
551 HAEMOGLOBIN DECREASED 2 0.0000
552 ERYTHEMA 4 0.0000
553 DYSPNOEA 11 0.0000
554 INFLAMMATION 1 0.0000
555 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
556 ECZEMA 1 0.0000
557 SPEECH DISORDER 1 0.0000
558 BRADYCARDIA 1 0.0000
559 PLATELET COUNT DECREASED 2 0.0000
560 DRUG EFFECT DECREASED 1 0.0000
561 PNEUMONIA 6 0.0000
562 DRUG INEFFECTIVE 24 0.0000
563 PANCYTOPENIA 1 0.0000
564 ABDOMINAL DISCOMFORT 3 0.0000
565 HYPONATRAEMIA 1 0.0000
566 EYE PAIN 1 0.0000
567 FLATULENCE 1 0.0000
568 HERPES ZOSTER 1 0.0000
569 LETHARGY 1 0.0000
570 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
571 DYSPHONIA 1 0.0000
572 CATARACT 1 0.0000
573 EMOTIONAL DISTRESS 2 0.0000
574 THERAPEUTIC RESPONSE DECREASED 1 0.0000
575 NAUSEA 13 0.0000
576 FEELING HOT 1 0.0000
577 DIZZINESS 8 0.0000
578 PRODUCT USE ISSUE 3 0.0000
579 LOSS OF CONSCIOUSNESS 2 0.0000
580 RHINORRHOEA 1 0.0000
581 AMNESIA 1 0.0000
582 BLOOD CREATININE INCREASED 1 0.0000
583 DEVICE DIFFICULT TO USE 1 0.0000
584 FEBRILE NEUTROPENIA 1 0.0000
585 BLOOD PRESSURE DECREASED 1 0.0000
586 DRY SKIN 2 0.0000
587 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
588 ARTHRALGIA 6 0.0000
589 SLEEP DISORDER 1 0.0000
590 HYPERTENSION 3 0.0000
591 OVERDOSE 3 0.0000
592 CONSTIPATION 3 0.0000
593 UNDERDOSE 1 0.0000
594 HALLUCINATION 1 0.0000
595 HOT FLUSH 1 0.0000
596 BLOOD PRESSURE INCREASED 2 0.0000
597 DRUG DEPENDENCE 2 0.0000
598 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
599 RENAL IMPAIRMENT 1 0.0000
600 MYOCARDIAL INFARCTION 2 0.0000
601 TACHYCARDIA 1 0.0000
602 GASTROINTESTINAL DISORDER 1 0.0000
603 DEVICE ISSUE 1 0.0000
604 SUICIDAL IDEATION 1 0.0000
605 MUSCLE SPASMS 2 0.0000
606 OROPHARYNGEAL PAIN 1 0.0000
607 CARDIAC DISORDER 1 0.0000
608 GAIT DISTURBANCE 2 0.0000
609 DEATH 9 0.0000
610 CONTUSION 1 0.0000
611 ATRIAL FIBRILLATION 1 0.0000
612 HAEMORRHAGE 1 0.0000
613 DIARRHOEA 6 0.0000
614 FALL 3 0.0000
615 SEPSIS 1 0.0000
616 THROMBOCYTOPENIA 1 0.0000
617 RHEUMATOID ARTHRITIS 1 0.0000
618 PALPITATIONS 1 0.0000
619 DISEASE PROGRESSION 1 0.0000
620 OEDEMA PERIPHERAL 1 0.0000
621 VISUAL IMPAIRMENT 1 0.0000
622 RENAL FAILURE 1 0.0000
623 VISION BLURRED 1 0.0000
624 CONFUSIONAL STATE 1 0.0000
625 MYALGIA 1 0.0000